CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback